Showing results (1-10 of 153) with videos related to
Sort By:
Pageof 16
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 7, 2000
Low versus standard dose mCPP challenge in obsessive-compulsive patientsS Erzegovesi, L Martucci, M Henin, et al.Psychiatry Research|October 16, 1995
Serum cholinesterase in obsessive-compulsive disorderS Erzegovesi, L Bellodi, E SmeraldiEuropean Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 1, 1997
Predictive value of obsessive-compulsive personality disorder in antiobsessional pharmacological treatmentP Cavedini, S Erzegovesi, P Ronchi, et al.The Pharmacogenomics Journal|June 26, 2002
Obsessive-Compulsive Disorder, 5-HTTLPR polymorphism and treatment responseD Di Bella, S Erzegovesi, M C Cavallini, et al.Neuropsychologia|October 15, 2020
Visuo-tactile shape perception in women with Anorexia Nervosa and healthy women with and without body concernsG Risso, R M Martoni, S Erzegovesi, et al.Psychiatry Research|March 3, 1997
Plasma tryptophan levels and tryptophan/neutral amino acid ratios in obsessive-compulsive patients with and without depressionL Bellodi, S Erzegovesi, L Bianchi, et al.Journal of Clinical Psychopharmacology|October 11, 2001
Clinical predictors of drug response in obsessive-compulsive disorderS Erzegovesi, M C Cavallini, P Cavedini, et al.Comprehensive Psychiatry|January 1, 1997
Relationship between obsessive-compulsive personality disorder and obsessive-compulsive disorderG Diaferia, I Bianchi, M L Bianchi, et al.Biological Psychiatry|September 1, 1996
Tryptophan depletion in obsessive-compulsive patientsE Smeraldi, G Diaferia, S Erzegovesi, et al.Psychiatry Research|April 16, 1998
5HT2C CYS23/SER23 polymorphism is not associated with obsessive-compulsive disorderM C Cavallini, D Di Bella, L Pasquale, et al.Pageof 16